Heat-shock factor 2 is a suppressor of prostate cancer invasion

Oncogene

Volumn 35, Issue 14, 2016, Pages 1770-1784

  Bjork J K ^a,b   Akerfelt M ^a,b   Joutsen, J ^a,c   Puustinen, M C ^a,c   Cheng, F ^a,c   Sistonen, L ^a,c   Nees, M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; CADHERIN 2; COLLAGEN TYPE 6ALPHA; FIBROBLAST SPECICIFIC PROTEIN 1; FIBRONECTIN; FIBRONECTIN 1; FILAMIN A; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; HEAT SHOCK FACTOR 2; HEAT SHOCK PROTEIN; HEAT SHOCK TRANSCRIPTION FACTOR 1; LAMININ; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; P21 ACTIVATED KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN P53; RAC PROTEIN; RHO KINASE; RHO KINASE 2; RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; VIMENTIN; HSF2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CELL DEATH; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL LEVEL; CELL MATURATION; CELL MOTION; CELL PLASTICITY; CELL PROLIFERATION; CELL STRUCTURE; CHORIOALLANTOIS; CHROMATIN; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; EMBRYO; EMBRYONAL CARCINOMA; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM TUMOR; EXTRACELLULAR MATRIX; FOCAL ADHESION; GENE CONTROL; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLEASON SCORE; GLIOBLASTOMA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KIDNEY CARCINOMA; LIPID HOMEOSTASIS; LYMPH NODE METASTASIS; MALE; MITOSIS; MOUSE; NONHUMAN; PAPILLARY CARCINOMA; PHENOTYPE; PLOIDY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM CELL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SMALL CELL LUNG CANCER; TISSUE STRUCTURE; TUMOR DIFFERENTIATION; TUMOR INVASION; UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; BIOMARKERS, TUMOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MALE; MICE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84933545153     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.241     Document Type: Article

References (75)

1. Massard C, Fizazi K. Targeting continued androgen receptor signaling in prostate cancer. Clin Cancer Res 2011; 17: 3876-3883
2. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LLISUP Grading Committee, The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242
3. Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011; 147: 992-1009
4. Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 2010; 11: 353-365
5. Härmä V, Virtanen J, Mäkelä R, Happonen A, Mpindi JP, Knuuttila M et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 2010; 5: e10431
6. Morin P, Wickman G, Munro J, Inman GJ, Olson MF. Differing contributions of LIMK and ROCK to TGFbeta-induced transcription, motility and invasion. Eur J Cell Biol 2011; 90: 13-25
7. Härmä V, Knuuttila M, Virtanen J, Mirtti T, Kohonen P, Kovanen P et al. Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models. Oncogene 2012; 31: 2075-2089
8. Björk JK, Sistonen L. Regulation of the members of the mammalian heat shock factor family. FEBS J 2010; 277: 4126-4139
9. Åkerfelt M, Morimoto RI, Sistonen L, Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol, 2010. 11. 545-555.
10. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007; 130: 1005-1018
11. Santagata S, Mendillo ML, Tang YC, Subramanian A, Perley CC, Roche SP et al. Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. Science 2013; 341: 1238303
12. Vihervaara A, Sergelius C, Vasara J, Blom MA, Elsing AN, Roos-Mattjus P et al. Transcriptional response to stress in the dynamic chromatin environment of cycling and mitotic cells. Proc Natl Acad Sci USA 2013; 110: E3388-E3397
13. Min JN, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 2007; 26: 5086-5097
14. Jin X, Moskophidis D, Mivechi NF. Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome. Cell Metab 2011; 14: 91-103
15. Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE et al. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci USA 2011; 108: 18378-18383
16. Mendillo ML, Santagata S, Koeva M, Bell GW, Hu R, Tamimi RM et al. HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers. Cell 2012; 150: 549-562
17. Scherz-Shouval R, Santagata S, Mendillo ML, Sholl LM, Ben-Aharon I, Beck AH et al. The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell 2014; 158: 564-578
18. Loison F, Debure L, Nizard P, le Goff P, Michel D, le Drean Y. Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. Biochem J 2006; 395: 223-231
19. Östling P, Björk JK, Roos-Mattjus P, Mezger V, Sistonen L. Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1. J Biol Chem, 2007. 282, 7077-7086.
20. Sandqvist A, Björk JK, Åkerfelt M, Chitikova Z, Grichine A, Vourc'h C et al. Heterotrimerization of heat-shock factors 1 and 2 provides a transcriptional switch in response to distinct stimuli. Mol Biol Cell 2009; 20: 1340-1347
21. El Fatimy R, Miozzo F, Le Mouel A, Abane R, Schwendimann L, Saberan-Djoneidi D et al. Heat shock factor 2 is a stress-responsive mediator of neuronal migration defects in models of fetal alcohol syndrome. EMBO Mol Med 2014; 6: 1043-1061
22. Elsing AN, Aspelin C, Bjork JK, Bergman HA, Himanen SV, Kallio MJ et al. Expression of HSF2 decreases in mitosis to enable stress-inducible transcription and cell survival. J Cell Biol 2014; 206: 735-749
23. Solimini NL, Luo J, Elledge SJ. Non-oncogene addiction and the stress phenotype of cancer cells. Cell 2007; 130: 986-988
24. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11-22
25. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-404
26. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1
27. Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007; 4: 359-365
28. Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007; 8: 839-845
29. Härmä V, Schukov HP, Happonen A, Ahonen I, Virtanen J, Siitari H et al. Quantification of Dynamic Morphological Drug Responses in 3D Organotypic Cell Cultures by Automated Image Analysis. PLoS One 2014; 9: e96426
30. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273
31. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4: 3
32. Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010; 8: 23
33. Kelly P, Casey PJ, Meigs TE. Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis. Biochemistry 2007; 46: 6677-6687
34. Rasheed SA, Teo CR, Beillard EJ, Voorhoeve PM, Casey PJ. MicroRNA-182 and microRNA-200a control G-protein subunit alpha-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. J Biol Chem 2013; 288: 7986-7995
35. Tcherkezian J, Lamarche-Vane N. Current knowledge of the large RhoGAP family of proteins. Biol Cell 2007; 99: 67-86
36. Sinha S, Yang W. Cellular signaling for activation of Rho GTPase Cdc42. Cell Signal 2008; 20: 1927-1934
37. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890
38. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674
39. Acloque H, Thiery JP, Nieto MA. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep 2008; 9: 322-326
40. Dagg CP, Karnofsky DA, Roddy J. Growth of transplantable human tumors in the chick embryo and hatched chick. Cancer Res 1956; 16: 589-594
41. Kunzi-Rapp K, Genze F, Kufer R, Reich E, Hautmann RE, Gschwend JE. Chorioallantoic membrane assay: vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model. J Urol 2001; 166: 1502-1507
42. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M et al. Tumor cell traffic through the extracellular matrix is controlled by the membraneanchored collagenase MT1-MMP. J Cell Biol 2004; 167: 769-781
43. Wang X, Wilson MJ, Slaton JW, Sinha AA, Ewing SL, Pei D. Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP). J Androl 2009; 30: 259-274
44. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6: 1-6
45. Ahlskog JK, Björk JK, Elsing AN, Aspelin C, Kallio M, Roos-Mattjus P et al. Anaphase-promoting complex/cyclosome participates in the acute response to protein-damaging stress. Mol Cell Biol 2010; 30: 5608-5620
46. Björk JK, Sandqvist A, Elsing AN, Kotaja N, Sistonen L. miR-18, a member of Oncomir-1, targets heat shock transcription factor 2 in spermatogenesis. Development 2010; 137: 3177-3184
47. Rossi A, Riccio A, Coccia M, Trotta E, La Frazia S, Santoro MG. The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes. J Biol Chem 2014; 289: 12705-12715
48. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445-457
49. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-336
50. Burns-Cox N, Avery NC, Gingell JC, Bailey AJ. Changes in collagen metabolism in prostate cancer: a host response that may alter progression. J Urol 2001; 166: 1698-1701
51. Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010; 24: 1967-2000
52. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200-204
53. Marino N, Nakayama J, Collins JW, Steeg PS. Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene. Cancer Metast Rev 2012; 31: 593-603
54. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11. 2. Science 1995; 268: 884-886
55. Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer PJ et al. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. Proc Natl Acad Sci USA 1998; 95: 11307-11311
56. Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H et al. Systematic bioinformatic analysis of expression levels of 17, 330 human genes across 9, 783 samples from types of healthy and pathological tissues. Genome Biol 2008; 9: R139
57. Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G et al. hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. Cancer Res 2006; 66: 3531-3540
58. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997; 3: 402-408
59. Hulsen T, de Vlieg J, Alkema W. BioVenn-a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genom 2008; 9: 488
60. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD et al. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 2005; 11: 5730-5739
61. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13. 31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006; 66: 820-827
62. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001; 98: 13790-13795
63. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 2005; 65: 5588-5598
64. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403
65. Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A, Watson MA. Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res 2002; 62: 2085-2091
66. Kimchi ET, Posner MC, Park JO, Darga TE, Kocherginsky M, Karrison T et al. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res 2005; 65: 3146-3154
67. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14: 518-527
68. Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, Kovacs G. Highresolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 2009; 9: 152
69. Adib TR, Henderson S, Perrett C, Hewitt D, Bourmpoulia D, Ledermann J et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 2004; 90: 686-692
70. Durig J, Bug S, Klein-Hitpass L, Boes T, Jons T, Martin-Subero JI et al. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia 2007; 21: 2153-2163
71. Haslinger C, Schweifer N, Stilgenbauer S, Dohner H, Lichter P, Kraut N et al. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 2004; 22: 3937-3949
72. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001; 98: 1176-1181
73. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genom 2008; 1: 13
74. Choi YL, Tsukasaki K, O'Neill MC, Yamada Y, Onimaru Y, Matsumoto K et al. A genomic analysis of adult T-cell leukemia. Oncogene 2007; 26: 1245-1255
75. Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R et al. Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 2009; 9: 11